Genetic manipulation of established PD susceptibility genes, including PARK2 [44, 45] and VPS35 [46], modulate α-synuclein toxicity in transgenic flies, similar to findings in mammalian models [44, 47]. The gene discussed is PRKN; the disease is Parkinson disease.